GlobeNewswire Inc.·1d ago·NaLifecore Biomedical Lands Third Commercial Site Transfer in Medical Aesthetics PushLifecore Biomedical announces third commercial CDMO site transfer since October 2025, targeting 12% revenue CAGR through 2029. LFCRCDMOcontract manufacturing
GlobeNewswire Inc.·Mar 17·Johnson Fistel, PllpGreen Dot Stock Tumbles 7% as Law Firm Eyes Securities ClaimsGreen Dot shares fell 7% after delaying Q4/2025 earnings, triggering securities investigation by Johnson Fistel examining potential disclosure violations. GDOTHRZNHTFCLFCRsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 16·Johnson Fistel, PllpLifecore Biomedical Shareholders Face Steep Losses as Law Firm Launches Securities InvestigationJohnson Fistel investigates Lifecore Biomedical over 15-18% revenue miss and 18% stock decline, offering shareholder recovery options for alleged securities law violations. HRZNHTFCGIIILFCRinvestor lossesshareholder rights